An Efficient One-Pot Multicomponent Synthesis of Tetracyclic Quinazolino[4,3-b]quinazolines by Sequential C–N Bond Formation and Copper-Mediated Aerobic Oxidative Cyclization

Abstract

An efficient one-pot synthesis of quinazolino[4,3-b]quinazoline derivatives has been accomplished, starting from 2-(2-bromo­phenyl)quinazolin-4(3H)-one, aldehydes, and various nitrogen sources under aerobic conditions. The multicomponent protocol is mediated by copper(I) salts and involves amination of 2-(2-bromophenyl)quinazolin-4(3H)-one, followed by condensation with the aldehyde and an oxidative cyclization to give the target compounds in moderate to good yields.

Key words

quinazolinoquinazoline - copper catalysis - oxidative cyclization - C–N bond formation.

• References

• 1a Michael JP. Nat. Prod. Rep. 2008; 25: 166
• 1b Michael JP. Nat. Prod. Rep. 2007; 24: 223
• 1c Michael JP. Nat. Prod. Rep. 2005; 22: 627
• 2a Göker H. Özden S. Yilidz S. Boykin DW. Eur. J. Med. Chem. 2005; 40: 1062
• 2b Malecki N. Carato P. Rigo B. Goossens J.-F. Houssin R. Bailly C. Hénichart J.-P. Bioorg. Med. Chem. 2014; 12: 641
• 3 Colotta V. Catarzi D. Varano F. Lenzi O. Filacchioni G. Costagli G. Galli A. Ghelardini C. Galeotti N. Gratteri P. Sgrignani J. Deflorian F. Moro S. J. Med. Chem. 2006; 49: 6015
• 4a Maggio B. Daidone G. Raffa D. Plescia S. Mantione L. Catena Cutuli VA. Mangano NG. Caruso A. Eur. J. Med. Chem. 2001; 36: 737
• 4b Laddha SL. Bhatnagar SP. Bioorg. Med. Chem. 2009; 17: 6796
• 4c Aly MM. Mohamed YA. El-Bayouki KA. M. Basyouni WM. Abbas SY. Eur. J. Med. Chem. 2010; 45: 3365
• 4d Khan I. Ibrar A. Abbas N. Saeed A. Eur. J. Med. Chem. 2014; 76: 193
• 4e Ugale VG. Bari SB. Eur. J. Med. Chem. 2014; 80: 447
• 4f Maurya HK. Verma R. Alam S. Pandey S. Pathak V. Sharma S. Srivastava KK. Negi AS. Gupta A. Bioorg. Med. Chem. Lett. 2013; 23: 5844
• 5 Latermann AB. Chen D. McCutcheon K. Hoffman G. Frias E. Ruddy D. Rakiec D. Korn J. McAllister G. Stegmeier F. Meyer MJ. Sharma SV. Cancer Res. 2015; 75: 4937
• 6 Chen C.-H. Statt S. Chiu C.-L. Thai P. Arif M. Adler KB. Wu R. Am. J. Respir. Crit. Care Med. 2014; 190: 1127
• 7 Ayala-Ramirez M. Feng L. Habra MA. Dickson PV. Perreier N. Phan A. Waguespack S. Patel S. Jimenez C. Cancer 2012; 118: 2804
• 8 Tseng MC. Chu Y.-W. Tasi H.-P. Lin C.-M. Hwang J. Chu Y.-H. Org. Lett. 2011; 13: 920
• 9 Dzierzbicka K. Trzonokowski P. Sewerynek PL. Myśliwski A. J. Med. Chem. 2003; 46: 978
• 10 Li H. Li W. Spannenberg A. Baumann W. Neumann H. Beller M. Wu X.-F. Chem. Eur. J. 2014; 20: 8541
• 11a Utkina NK. Denisenko V. Tetrahedron Lett. 2007; 48: 4445
• 11b Mason JJ. Janosik T. Bergman J. Synthesis 2009; 3642
• 12 Kshirsagar UA. Puranik VG. Argade NP. J. Org. Chem. 2010; 75: 2702
• 13a Alexandre FR. Berecibar A. Wrigglesworth R. Besson T. Tetrahedron 2003; 59: 1413
• 13b Adepu R. Sunke R. Meda CL. T. Ramudu D. Krishna GR. Reddy CM. Deora GS. Parsa KV. L. Pal M. Chem. Commun. 2013; 49: 190
• 13c Saha B. Kumar R. Maulik PR. Kundu B. Tetrahedron Lett. 2006; 47: 2765
• 13d Cai Q. Li Z. Wei J. Fu L. Ha C. Pei D. Ding K. Org. Lett. 2010; 12: 1500
• 13e Tyagi V. Khan S. Bajpai V. Gauniyal HM. Kumar B. Chauhan PM. S. J. Org. Chem. 2012; 77: 1414
• 14 Reddy MB. Reddy PG. Shailaja M. Manjula A. Rao TP. RSC Adv. 2016; 6: 98297
• 15 Xu C. Jia FC. Zhou Z.-W. Zheng S.-J. Li H. Wu A.-X. J. Org. Chem. 2016; 81: 3000
• 16 Quinazolino[4,3-b]quinazolines 4a–r; General Procedures Method 1 (NaN₃ as the nitrogen source): CuI (10 mol%), l-proline (20 mol %), and NaN₃ (3 mmol) were added to a solution of quinazolinone 1 (1.66 mmol) in DMSO (5 mL) at r.t., and a blue complex formed. The appropriate aldehyde (2 mmol) was added, and the mixture was stirred at 80 °C for 12 h until the reaction was complete (TLC). The mixture was cooled then partitioned between ice-cold H₂O (25 mL) and EtOAc (30 mL). The organic layer was separated, and the aqueous layer was extracted with EtOAc (2 × 30 mL). The organic layers were combined, washed with brine, dried (Na₂SO₄), filtered, and concentrate in vacuo. The residue was purified by column chromatography (silica gel). Method 2 (aq NH₃ as the nitrogen source): CuI (10mol %), l-proline (20 mol %), 25% aq NH₃ (1 mL), K₂CO₃ (5 mmol), and the appropriate aldehyde (2 mmol) were added to a solution of quinazolinone 1 ²² (1.66 mmol) in DMSO (5 mL), and mixture was stirred at 100 °C for 6 h in a sealed tube. The mixture was then heated for 18 h open to the air until the reaction was complete (TLC). The mixture was cooled to r.t. then partitioned between ice-cold H₂O (25 mL) and EtOAc (30 mL). The organic layer was separated, and the aqueous layer was extracted with EtOAc (2 × 30 mL). The organic layers were combined, washed with brine, dried (Na₂SO₄), filtered, and concentrated in vacuo. The residue was purified by column chromatography (silica gel). 6-(4-Bromophenyl)-8H-quinazolino[4,3-b]quinazolin-8-one (4g) White solid; yield: 482 mg (72%); mp 270–272 °C. IR (KBr): 1696 (C=O) cm^–1. ¹H NMR (400 MHz, CDCl₃): δ = 8.81 (d, J = 8.0 Hz, 1 H), 8.24 (d, J = 7.9 Hz, 1 H), 7.88 (d, J = 3.5 Hz, 2 H), 7.85–7.78 (m, 2 H), 7.66–7.63 (m, 1 H), 7.62–7.59 (m, 2 H), 7.52–7.50 (m, 1 H), 7.49 (d, J = 8.2 Hz, 2 H). ¹³C NMR (100 MHz, CDCl₃): δ = 160.54 (C=O), 148.96, 146.92, 146.15, 144.21, 142.28, 135.96, 135.58, 133.70, 131.40, 128.62, 127.99, 127.40, 127.18, 126.52, 126.01, 124.01, 121.42, 120.29. LC-MS (positive-ion mode): m/z = 402 [M + H]⁺; HRMS (EI): m/z [M + H]⁺ calcd for C₂₁H₁₃BrN₃O: 402.02404; found: 402.02365.6-(4-Nitrophenyl)-8H-quinazolino[4,3-b]quinazolin-8-one (4i) Yellow solid; yield: 246 (43%); mp 288–290 °C. IR (KBr): 1692 (C=O) cm ^–1. ¹H NMR (400 MHz, CDCl₃): δ = 8.85 (d, J = 8.0 Hz, 1 H), 8.35 (d, J = 8.7 Hz, 2 H), 8.23 (d, J = 7.9 Hz, 1 H), 7.91 (d, J = 2.3 Hz, 2 H), 7.85 (d, J = 6.5 Hz, 2 H), 7.75 (d, J = 8.7 Hz, 2 H), 7.69 (t, J = 7.3 Hz, 1 H), 7.55–7.50 (m, 1 H). ¹³C NMR (100 MHz, CDCl₃): δ = 160.33 (C=O), 147.97, 147.81, 146.92, 145.70, 143.27, 141.97, 135.89, 133.91, 129.39, 128.26, 127.94, 127.37, 126.83, 126.13, 123.50, 121.39, 119.97. LC-MS (positive-ion mode): m/z = 369 [M + H]⁺; HRMS (EI): m/z [M + H]⁺ calcd for C₂₁H₁₃N₄O₃: 369.0988; found: 369.0986.
• 17 Sang P. Xie Y. Zou J. Zhang Y. Org. Lett. 2012; 14: 3894
• 18 Kotipalli T. Kavala V. Janreddy D. Bandi V. Kuo CW. Yao CF. Eur. J. Org. Chem. 2016; 1182
• 19a Li B. Zhang B. Zhang X. Fan X. J. Org. Chem. 2016; 81: 9530
• 19b Guo S. Li Y. Tao L. Zhang W. Fan X. RSC Adv. 2014; 4: 59289
• 20a Jia F.-C. Zhou Z.-W. Xu C. Cai Q. Li D.-K. Wu A.-X. Org. Lett. 2015; 17: 4236
• 20b Kim Y. Kumar MR. Park N. Yeo Y. Lee S. J. Org. Chem. 2011; 76: 9577
• 20c Rai B. Kumar P. Kumar A. RSC Adv. 2015; 5: 85915
• 21 Markiewicz JT. Wiest O. Helquist P. J. Org. Chem. 2010; 75: 4887-4890
• 22a Tian X. Song L. Li E. Wang Q. Yu W. Chang J. RSC Adv. 2015; 5: 62194
• 22b Gawande SS. Warangkar SC. Bandgar BP. Khobragade CN. Bioorg. Med. Chem. 2013; 21: 2772